Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 6
2007 1
2008 3
2011 1
2012 3
2013 1
2014 1
2016 6
2017 2
2018 2
2019 3
2021 4
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Does the use of acetylsalicylic acid have an influence on our vision?
Michalska-Małecka K, Regucka A, Śpiewak D, Sosnowska-Pońska M, Niewiem A. Michalska-Małecka K, et al. Clin Interv Aging. 2016 Nov 3;11:1567-1574. doi: 10.2147/CIA.S115234. eCollection 2016. Clin Interv Aging. 2016. PMID: 27843305 Free PMC article. Review.
Local T cell infiltrates are predominantly associated with corneal allograft rejection.
Sakowska J, Glasner P, Dukat-Mazurek A, Rydz A, Zieliński M, Pellowska I, Biernat W, Glasner L, Michalska-Małecka K, Trzonkowski P. Sakowska J, et al. Among authors: michalska malecka k. Transpl Immunol. 2023 Aug;79:101852. doi: 10.1016/j.trim.2023.101852. Epub 2023 May 16. Transpl Immunol. 2023. PMID: 37196866 Free article.
Incidence and Characteristics of Cataract Surgery in Poland, during 2010-2015.
Nowak MS, Grabska-Liberek I, Michalska-Małecka K, Grzybowski A, Kozioł M, Niemczyk W, Więckowska B, Szaflik JP. Nowak MS, et al. Among authors: michalska malecka k. Int J Environ Res Public Health. 2018 Mar 2;15(3):435. doi: 10.3390/ijerph15030435. Int J Environ Res Public Health. 2018. PMID: 29498697 Free PMC article.
43 results